|
1
|
Report of the national high blood pressure
education program working group on high blood pressure in
pregnancy. Am J Obstet Gynecol. 183 (Suppl 1):S1–S22.
2000.PubMed/NCBI
|
|
2
|
Sibai BM and Stella CL: Diagnosis and
management of atypical preeclampsia-eclampsia. Am J Obstet Gynecol.
200(481)2009.PubMed/NCBI View Article : Google Scholar
|
|
3
|
American College of Obstetricians and
Gynecologists' Committee on Practice Bulletins-Obstetrics.
Gestational hypertension and preeclampsia: ACOG practice Bulletin,
Number 222. Obstet Gynecol. 135:e237–e260. 2020.
|
|
4
|
https://www.nice.org.uk/guidance/qs35/chapter/quality-statement-2-antenatal-assessment-of-pre-eclampsia-risk#what-the-quality-statement-means-for-service-providers-healthcare-practitioners-and-commissioners-2.
Accessed November 2, 2020.
|
|
5
|
Myatt L, Clifton RG, Roberts JM, Spong CY,
Hauth JC, Varner MW, Thorp JM Jr, Mercer BM, Peaceman AM, Ramin SM,
et al: First-Trimester prediction of preeclampsia in nulliparous
women at low risk. Eunice kennedy shriver national institute of
child health and human development (NICHD) maternal-fetal medicine
units (MFMU) network. Obstet Gynecol. 119:1234–1242.
2012.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Bartsch E, Medcalf KE, Park AL and Ray JG:
High risk of pre-eclampsia identification group: Clinical risk
factors for pre-eclampsia determined in early pregnancy: Systematic
review and meta-analysis of large cohort studies. BMJ.
353(i1753)2016.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Lee RM, Brown MA, Branch DW, Ward K and
Silver RM: Anticardiolipin and anti-B2 glycoprotein-I antibodies in
preeclampsia. Obstet Gynecol. 102:294–300. 2003.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Opatrny L, David M, Kahn SR, Shrier I and
Rey E: Association between antiphospholipid antibodies and
recurrent fetal loss in women without autoimmune disease: A
metaanalysis. J Rheumatol. 33:2214–2221. 2006.PubMed/NCBI
|
|
9
|
Bohîlțea RE, Turcan N, Ionescu CA,
Mehedințu C, Nastasia Ș Toader O, Munteanu O and Cîrstoiu MM:
Ultrasound diagnosis of abnormal adherent placenta-literature
review. Filodiritto Editore-Proceedings. 5th Romanian Congress of
the Romanian Society of Ultrasound in Obstetrics and Gynecolog:
113-119, 2017.
|
|
10
|
Devoe LD, Gardner P, Dear C and Castillo
RA: The diagnostic values of concurrent nonstress testing, amniotic
fluid measurement and doppler velocimetry in screening a high-risk
population. Am J Obstet Gynecol. 163:1040–1048. 1990.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Agrawal S, Cerdeira AS, Redman C and
Vatish M: Meta-analysis and systematic review to assess the role of
soluble FMS-like tyrosine kinase-1 and placenta growth factor ratio
in prediction of preeclampsia: The SaPPPhirE study. Hypertension.
71:306–316. 2018.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Kleinrouweler CE, Bossuyt PM,
Thilaganathan B, Vollebregt KC, Ramírez JA, Ohkuchi A, Deurloo KL,
Macleod M, Diab AE, Wolf H, et al: Value of adding second-trimester
uterine artery doppler to patient characteristics in identification
of nulliparous women at increased risk for pre-eclampsia: An
individual patient data meta-analysis. Ultrasound Obstet Gynecol.
42:257–267. 2013.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Dizon-Townson D, Miller C, Sibai B, Spong
CY, Thom E, Wendel G Jr, Wenstrom K, Samuels P, Cotroneo MA, Moawad
A, et al: National institute of child health and human development
maternal-fetal medicine units network. The relationship of the
factor V Leiden mutation and pregnancy outcomes for mother and
fetus. Obstet Gynecol. 106:517–524. 2005.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Silver RM, Zhao Y, Spong CY, Sibai B,
Wendel G Jr, Wenstrom K, Samuels P, Caritis SN, Sorokin Y,
Miodovnik M, et al: Eunice kennedy shriver national institute of
child health and human development maternal-fetal medicine units
(NICHD MFMU) network. Prothrombin gene G20210A mutation and
obstetric complications. Obstet Gynecol. 115:14–20. 2010.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Mello G, Parretti E, Marozio L, Pizzi C,
Lojacono A, Frusca T, Tondi F, Borri P, Scarselli G and Sibai BM:
Thrombophilia is significantly associated with severe preeclampsia.
Results of a large scale, care-controlled study. Hypertension.
46:1270–1274. 2005.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Voicu DI, Munteanu O, Gherghiceanu F,
Arsene LV, Bohillea RE, Gradinaru DM and Cirstoiu MM: Maternal
inherited thrombophilia and pregnancy outcomes. Exp Ther Med.
20:2411–2414. 2020.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Păuleț FP, Ţurcan N, Gherghiceanu F,
BohÞlţea RE, Nemescu D and CÞrstoiu MM: Prognosis of autoimmune
thyroid disease associated with hereditary thrombophilia during
pregnancy. Exp Ther Med. 20:2429–2433. 2020.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Paidas MJ, Ku DH and Arkel YS: Screening
and management of inherited thrombophilias in the setting of
adverse pregnancy outcome. Clin Perinatol. 31:783–805.
2004.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Sheikh M, Zoham MH, Hantoushzadeh S,
Shariat M, Dalili H and Amini E: Umbilical blood gas analysis in
preeclamptic versus healthy pregnancies with preterm birth. J
Matern Neonatal Med. 29:1–6. 2015.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Bohîlțea RE, Zugravu CA, Neacsu A, Navolan
D, Berceanu C, Nemescu D, Bodean O, Turcan N, Baros A and Cîrstoiu
MM: The prevalence of vitamin D deficiency and its obstetrical
effects. A prospective study on Romanian patients. Rev Chim.
70:1228–1233. 2019.
|
|
21
|
Tiglis M, Neagu TP, Elfara M, Diaconu CC,
Bratu OG, Vacaroiu IA and Grintescu IM: Nefopam and its role in
modulating acute and chronic pain. Rev Chim. 69:2877–2880.
2018.
|
|
22
|
Bohîlţea RE, Tufan CF, Cîrstoiu MM,
Dumitru AV, Georgescu TA, Sajin M, Bodean OM, Munteanu O, Brătilă
E, Ofiţeru AM and Berceanu C: Body stalk anomaly in a
monochorionic-diamniotic twin pregnancy-case report and review of
the literature. Rom J Morphol Embryol. 58:1453–1460.
2017.PubMed/NCBI
|
|
23
|
Nastas A, Stanculescu R, Mehedințu C,
Berceanu C, Comandasu D, Cîrstoiu M, Bohîlțea R, Vladareanu S,
Patrascoiu S, Nastas AL and Bratilă E: The management of grade
II/III hydronephrosis during pregnancy. Proceedings of Filodiritto
Editore-Proceedings, The 13th National Congress of Urogynecology
(UROGYN 2016): 195-199, 2016.
|
|
24
|
Munteanu O, Cîrstoiu MM, Filipoiu FM,
Bohîlțea RE, Brătilă E, Bulescu IA and Berceanu C: Morphological
and ultrasonographic study of fetuses with cervical hygroma. A case
series. Rom J Morphol Embriol. 57:1421–1427. 2016.PubMed/NCBI
|
|
25
|
Homer CS, Brown MA, Mangos G and Davis GK:
Non-Proteinuric pre-eclampsia: A novel risk indicator in women with
gestational hypertension. J Hypertens. 26:295–302. 2008.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Bohîlțea R, Furtunescu F, Turcan N,
Navolan D, Ducu I and Cîrstoiu M: Prematurity and intrauterine
growth restriction: Comparative analysis of incidence and short
term complication. Proceedings of SOGR 2018. The 17th National
Congress of the Romanian Society of Obstetrics and Gynecology.
2018:708–712. 2019.
|
|
27
|
Turcan N, Bohiltea RE, Ionita-Radu F,
Furtunescu F, Navolan D, Berceanu C, Nemescu D and Cirstoiu MM:
Unfavorable influence of prematurity on the neonatal prognostic of
small for gestational age fetuses. Exp Ther Med. 20:2415–2422.
2020.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Bohîlțea R, Turcan N, Ionescu C, Toader O,
Nastasia S, Neculcea D, Movileanu I, Munteanu O and Cîrstoiu M: The
incidence of prematurity and associated short-term complications in
a multidisciplinary emergency hospital from Romania. 5th Romanian
Congress of the Romanian Society of Ultrasound in Obstetrics and
Gynecology: 105-112, 2017.
|
|
29
|
Gestational Hypertension and Preeclampsia.
ACOG practice bulletin summary, number 222. Obstet Gynecol.
135:1492–1495. 2020.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Bohiltea RE, Zugravu CA, Nemescu D, Turcan
N, Paulet FP, Gherghiceanu F, Ducu I and Cirstoiu MM: Impact of
obesity on the prognosis of hypertensive disorders in pregnancy.
Exp Ther Med. 20:2423–2428. 2020.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Gerhardt A, Scharf RE, Beckmann MW, Struve
SP, Bender HG, Pillny M, Sandmann W and Zotz RB: Prothrombin and
factor V mutations in women with a history of thrombosis during
pregnancy and the puerperium. N Engl J Med. 342:374–380.
2000.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Benedetto C, Marozio L, Tavella AM, Salton
L, Grivon S and Di Giampaolo F: Coagulation disorders in pregnancy:
Acquired and inherited thrombophilias. Ann NY Acad Sci.
1205:106–117. 2010.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Van der Meer FJ, Koster T, Vandenbroucke
JP, Briët E and Rosendaal FR: The leiden thrombophilia study
(LETS). Thromb Haemost. 78:631–635. 1997.PubMed/NCBI
|
|
34
|
Kocher O, Cirovic C, Malynn E, Rowland CM,
Bare LA, Young BA, Henslee JG, Laffler TG, Huff JB, Kruskall MS, et
al: Obstetric complications in patients with hereditary
thrombophilia identified using the LCx microparticle enzyme
immunoassay: A controlled study of 5,000 patients. Am J Clin
Pathol. 127:68–75. 2007.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Turcan N, Bohîlțea R, Neacsu A, Baros Al
and Cîrstoiu MM: The role of anticoagulant therapy in the
prevention of preeclampsia. Pharmacokinetic and pharmacodinamic
mechanisms. Rev Chim. 70:1424–1428. 2019.
|
|
36
|
Rey E, Kahn SR, David M and Shrier I:
Thrombophilic disorders and fetal loss: A meta-analysis. Lancet.
361:901–908. 2003.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Mogos M, Herghelegiu CG, Ioan RG, Cringu
AI and Neacsu A: Determining an umbilical cord pH cutoff value for
predicting neonatal morbidity related to intrapartum hypoxia. Rev
Chim. 70:605–607. 2019.
|
|
38
|
Heit JA, Kobbervig CA, James HA, Petterson
TM, Bailey KR and Melton LJ III: Trends in the incidence of venous
thromboembolism during pregnancy or postpartum: A 30-year
population-based study. Ann Intern Med. 143:697–706.
2005.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Bohiltea RE, Turcan G, Cirstoiu MM,
Ionescu C, Nemescu D, Turcan N and Vladareanu R: Clinical
implementation of ultrasound gynecological examination report
(software REGU) Based on International Consensuses of Tumor Study
Groups. 5th Romanian Congress of the Romanian Society of Ultrasound
in Obstetrics and Gynecology: 99-104, 2017.
|
|
40
|
DeVore GR: The importance of the
cerebroplacental ratio in the evaluation of fetal well-being in SGA
and AGA fetuses. Am J Obstet Gynecol. 213:5–15. 2015.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Ionescu AC, Popescu I, Banacu M, Matei A,
Bohîlțea R and Dimitriu M: Is it possible to predict stillbirth in
the third trimester? Filodiritto Editore-Proceedings. 5th Romanian
Congress of the Romanian Society of Ultrasound in Obstetrics and
Gynecology: 194-198, 2017.
|
|
42
|
Morris JM, Thompson K, Smithey J, Gaffney
G, Cooke I, Chamberlain P, Hope P, Altman D and MacKenzie IZ: The
usefulness of ultrasound assessment of amniotic fluid in predicting
adverse outcome in prolonged pregnancy: A prospective blinded
observational study. BJOG. 110:989–994. 2003.PubMed/NCBI
|
|
43
|
Roqué H, Paidas MJ, Funai EF, Kuczynski E
and Lockwood CJ: Maternal thrombophilias are not associated with
early pregnancy loss. Thromb Haemost. 91:290–295. 2004.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Van Pampus MG, Dekker GA, Wolf H, Huijgens
PC, Koopman MM, von Blomberg BM and Büller HR: High prevalence of
hemostatic abnormalities in women with a history of severe
preeclampsia. Am J Obstetrics Gynecol. 180:1146–1150.
1999.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Hossain N, Shamsi T and Soomro N:
Frequency of thrombophilia in patients with adverse pregnancy
outcome. J Pak Med Assoc. 55:245–247. 2005.PubMed/NCBI
|
|
46
|
Jivray S, Rai R, Underwood J and Regan L:
Genetic thrombophilic mutations among couples with recurrent
miscarriage. Hum Reprod. 21:1161–1165. 2006.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Alfirevic Z, Roberts D and Martlew V: How
strong is the association between maternal thrombophilia and
adverse pregnancy outcome? A systematic review. Eur J Obstet
Gynecol Reprod Biol. 101:6–14. 2002.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Lin J and August P: Genetic thrombophilias
and preeclampsia: A meta-analysis. Obstet Gynecol. 105:182–192.
2005.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Rey E, Garneau P, David M, Gauthier R,
Leduc L, Michon N, Morin F, Demers C, Kahn SR, Magee LA and Rodger
M: Dalteparin for the prevention of recurrence of
placental-mediated complications of pregnancy in women without
thrombophilia: A pilot randomized controlled trial. J Thromb
Haemost. 7:58–64. 2009.PubMed/NCBI View Article : Google Scholar
|
|
50
|
Mello G, Parretti E, Fatini C, Riviello C,
Gensini F, Marchionni M, Scarselli GF, Gensini GF and Abbate R:
Low-molecular-weight heparin lowers the recurrence rate of
preeclampsia and restores the physiological vascular changes in
angiotensin-converting enzyme DD women. Hypertension. 45:86–91.
2005.PubMed/NCBI View Article : Google Scholar
|
|
51
|
Bohîlţea RE, Cîrstoiu MM, Ionescu CA,
Niculescu-Mizil E, Vlădăreanu AM, Voican I, Dimitriu M and Turcan
N: Primary myelofibrosis and pregnancy outcomes after low
molecular-weight heparin administration: A case report and
literature review. Medicine (Baltimore). 96(e8735)2017.PubMed/NCBI View Article : Google Scholar
|
|
52
|
Antovic A, Blombäck M, Bremme K and He S:
The assay of overall haemostasis potential used to monitor the low
molecular mass (weight) heparin, dalteparin, treatment in pregnant
women with previous thromboembolism. Blood Coagul Fibrinolysis.
13:181–186. 2002.PubMed/NCBI View Article : Google Scholar
|
|
53
|
Rodger MA, Gris JC, de Vries JIP,
Martinelli I, Rey É, Schleussner E, Middeldorp S, Kaaja R, Langlois
NJ, Ramsay T, et al: Low-Molecular-Weight heparin for
placenta-mediated pregnancy complications study group.
low-molecular-weight heparin and recurrent placenta-mediated
pregnancy complications: A meta-analysis of individual patient data
from randomised controlled trials. Lancet. 388:2629–2641.
2016.PubMed/NCBI View Article : Google Scholar
|
|
54
|
RCOG (Royal College of Obstetricians and
Gynecologysts). Thromboprophylaxis during pregnancy, labor and
after vaginal delivery. RCOG Guideline No. 37, January 2004.
Accessed November 2, 2020.
|
|
55
|
Gates S, Brocklehurst P and Davis LJ:
Prophylaxis for venous thromboembolic disease in pregnancy and the
early postnatal period. Cochrane Database Syst Rev.
2002(CD001689)2002.PubMed/NCBI View Article : Google Scholar
|
|
56
|
Cardiovascular Disease Educational and
Research Trust; Cyprus Cardiovascular Disease Educational and
Research Trust; European Venous Forum; International Surgical
Thrombosis Forum; International Union of Angiology; Union
Internationale de Phlébologie. Prevention and treatment of venous
thromboembolism. International Consensus Statement. Guidelines
according to scientific evidence. Int Angiol. 25:101–161.
2006.PubMed/NCBI
|
|
57
|
Royal College of Obstetricians and
Gynaecologists (RCOG): Green-top guideline on reducing the risk of
venous thromboembolism during pregnancy and the puerperium, 3rd
edition, 2015. Accessed November 2, 2020.
|
|
58
|
Berghella V (ed): Maternal-Fetal Evidence
Based Guidelines. 3rd edition. pp254-283, 2017.
|
|
59
|
American College of Obstetricians and
Gynecologists Women's Health Care Physicians. ACOG Practice
Bulletin No. 138: Inherited thrombophilias in pregnancy. Obstet
Gynecol. 122:706–717. 2013.PubMed/NCBI View Article : Google Scholar
|
|
60
|
Robertson L, Wu O, Langhorne P, Twaddle S,
Clark P, Lowe GD, Walker ID, Greaves M, Brenkel I, Rega L, et al:
Thrombophilia in pregnancy: A systematic review. Br J Haematol.
132:171–196. 2006.PubMed/NCBI View Article : Google Scholar
|
